News Releases

News and information from The Leukemia & Lymphoma Society

Precision Medicine and Immunotherapy Hold Promise, Cost of Care Growing Obstacle

View full multimedia release here. (Rye Brook, NY – May 3, 2017) – The nation’s leading experts on blood cancers and healthcare policy convened yesterday in Washington, D.C. to discuss the ever-increasing cost barriers that patients and their families face to access high-quality care, as well as discuss cutting-edge blood cancer research and treatments. The event was organized by The Leukemia & Lymp...

Majority of 26,000 Calls to LLS Reflect Patient Financial Stress

(Rye Brook, NY – May 2, 2017) – The rising cost of treatment and care for blood cancer patients has reached a boiling point, according to The Leukemia & Lymphoma Society (LLS), with an increasing number of patients foregoing their medications or reducing the dosage or frequency of their doctor‐prescribed treatments solely for cost reasons. In 2016, LLS’s free Information Resource Center received more than...

Olympians Join LLS’s Iconic Team In Training Program

Two-time Olympic gold medalist and world record holder in Decathlon Ashton Eaton and 2016 Rio Olympic bronze medalist in Heptathlon Brianne Theisen-Eaton​ team up with LLS to fight cancer View full multimedia release here. RYE BROOK, N.Y. (April 11, 2017) – The world’s first and foremost sports endurance training program for charity, Team In Training, is teaming up with Olympic track and field st...

LLS Expands Innovative Therapy Acceleration Program with Novel Immunotherapy

Rye Brook, NY (April 5, 2017) - The Leukemia & Lymphoma Society (LLS) continues to advance the promising field of immunotherapy research, harnessing the body’s own immune system to fight cancer, with a $4 million funding commitment in an investigational therapy being developed by Forty Seven Inc. for lymphoma patients. There are approximately 630,000 patients in the United States living with non-Hodgkin lymp...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: